Health ❯ Healthcare ❯ Clinical Trials
Multiple Myeloma Head and Neck Cancer Melanoma Immunotherapy Precision Medicine Follicular Lymphoma Chronic Lymphocytic Leukaemia Chemotherapy Chronic Lymphocytic Leukemia Enzalutamide Therapy Breast Cancer Chronic Myeloid Leukemia Autoimmunity Myelofibrosis Phase 3 Trials Myeloproliferative Neoplasms B-cell Malignancies Gastroesophageal Cancer Neurofibromatosis Diffuse Large B-Cell Lymphoma Hepatocellular Carcinoma Radiopharmaceuticals Patient Outcomes Lymphoma Gastrointestinal Cancer Small Lymphocytic Lymphoma Renal Cell Carcinoma Lung Cancer Research
Early-phase Nature Medicine reports describe improved responses after donor FMT under rigorous biosafety, with larger confirmatory studies still required.
